The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cardiopulmonary Autotransfusion System-Global Market Insights and Sales Trends 2025
Synopsis
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion System market size is expected to reach US$ 654.2 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Cardiopulmonary Autotransfusion System in various end use industries. The expanding demands from the Heart Surgery, Great Organ Transplant Surgery and Other Surgery,, are propelling Cardiopulmonary Autotransfusion System market. Unwashed ATS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Washed ATS segment is estimated at % CAGR for the next seven-year period.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiopulmonary Autotransfusion System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiopulmonary Autotransfusion System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiopulmonary Autotransfusion System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiopulmonary Autotransfusion System covered in this report include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo and Wandong Health Sources, etc.
The global Cardiopulmonary Autotransfusion System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Global Cardiopulmonary Autotransfusion System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiopulmonary Autotransfusion System market, Segment by Type:
Unwashed ATS
Washed ATS
Global Cardiopulmonary Autotransfusion System market, by Application
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion System market size is expected to reach US$ 654.2 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Cardiopulmonary Autotransfusion System in various end use industries. The expanding demands from the Heart Surgery, Great Organ Transplant Surgery and Other Surgery,, are propelling Cardiopulmonary Autotransfusion System market. Unwashed ATS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Washed ATS segment is estimated at % CAGR for the next seven-year period.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiopulmonary Autotransfusion System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiopulmonary Autotransfusion System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiopulmonary Autotransfusion System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiopulmonary Autotransfusion System covered in this report include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo and Wandong Health Sources, etc.
The global Cardiopulmonary Autotransfusion System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Global Cardiopulmonary Autotransfusion System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiopulmonary Autotransfusion System market, Segment by Type:
Unwashed ATS
Washed ATS
Global Cardiopulmonary Autotransfusion System market, by Application
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cardiopulmonary Autotransfusion System Market Overview
1.1 Cardiopulmonary Autotransfusion System Product Overview
1.2 Cardiopulmonary Autotransfusion System Market Segment by Type
1.2.1 Unwashed ATS
1.2.2 Washed ATS
1.3 Global Cardiopulmonary Autotransfusion System Market Size by Type
1.3.1 Global Cardiopulmonary Autotransfusion System Market Size Overview by Type (2018-2029)
1.3.2 Global Cardiopulmonary Autotransfusion System Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cardiopulmonary Autotransfusion System Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2018-2023)
2 Global Cardiopulmonary Autotransfusion System Market Competition by Company
2.1 Global Top Players by Cardiopulmonary Autotransfusion System Sales (2018-2023)
2.2 Global Top Players by Cardiopulmonary Autotransfusion System Revenue (2018-2023)
2.3 Global Top Players by Cardiopulmonary Autotransfusion System Price (2018-2023)
2.4 Global Top Manufacturers Cardiopulmonary Autotransfusion System Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cardiopulmonary Autotransfusion System Market Competitive Situation and Trends
2.5.1 Cardiopulmonary Autotransfusion System Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Autotransfusion System Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2022)
2.7 Date of Key Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
2.8 Key Manufacturers Cardiopulmonary Autotransfusion System Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cardiopulmonary Autotransfusion System Status and Outlook by Region
3.1 Global Cardiopulmonary Autotransfusion System Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cardiopulmonary Autotransfusion System Historic Market Size by Region
3.2.1 Global Cardiopulmonary Autotransfusion System Sales in Volume by Region (2018-2023)
3.2.2 Global Cardiopulmonary Autotransfusion System Sales in Value by Region (2018-2023)
3.2.3 Global Cardiopulmonary Autotransfusion System Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cardiopulmonary Autotransfusion System Forecasted Market Size by Region
3.3.1 Global Cardiopulmonary Autotransfusion System Sales in Volume by Region (2024-2029)
3.3.2 Global Cardiopulmonary Autotransfusion System Sales in Value by Region (2024-2029)
3.3.3 Global Cardiopulmonary Autotransfusion System Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cardiopulmonary Autotransfusion System by Application
4.1 Cardiopulmonary Autotransfusion System Market Segment by Application
4.1.1 Heart Surgery
4.1.2 Great Organ Transplant Surgery
4.1.3 Other Surgery
4.2 Global Cardiopulmonary Autotransfusion System Market Size by Application
4.2.1 Global Cardiopulmonary Autotransfusion System Market Size Overview by Application (2018-2029)
4.2.2 Global Cardiopulmonary Autotransfusion System Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cardiopulmonary Autotransfusion System Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2018-2023)
5 North America Cardiopulmonary Autotransfusion System by Country
5.1 North America Cardiopulmonary Autotransfusion System Historic Market Size by Country
5.1.1 North America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cardiopulmonary Autotransfusion System Sales in Volume by Country (2018-2023)
5.1.3 North America Cardiopulmonary Autotransfusion System Sales in Value by Country (2018-2023)
5.2 North America Cardiopulmonary Autotransfusion System Forecasted Market Size by Country
5.2.1 North America Cardiopulmonary Autotransfusion System Sales in Volume by Country (2024-2029)
5.2.2 North America Cardiopulmonary Autotransfusion System Sales in Value by Country (2024-2029)
6 Europe Cardiopulmonary Autotransfusion System by Country
6.1 Europe Cardiopulmonary Autotransfusion System Historic Market Size by Country
6.1.1 Europe Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cardiopulmonary Autotransfusion System Sales in Volume by Country (2018-2023)
6.1.3 Europe Cardiopulmonary Autotransfusion System Sales in Value by Country (2018-2023)
6.2 Europe Cardiopulmonary Autotransfusion System Forecasted Market Size by Country
6.2.1 Europe Cardiopulmonary Autotransfusion System Sales in Volume by Country (2024-2029)
6.2.2 Europe Cardiopulmonary Autotransfusion System Sales in Value by Country (2024-2029)
7 Asia-Pacific Cardiopulmonary Autotransfusion System by Region
7.1 Asia-Pacific Cardiopulmonary Autotransfusion System Historic Market Size by Region
7.1.1 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cardiopulmonary Autotransfusion System Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cardiopulmonary Autotransfusion System Forecasted Market Size by Region
7.2.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cardiopulmonary Autotransfusion System Sales in Value by Region (2024-2029)
8 Latin America Cardiopulmonary Autotransfusion System by Country
8.1 Latin America Cardiopulmonary Autotransfusion System Historic Market Size by Country
8.1.1 Latin America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cardiopulmonary Autotransfusion System Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cardiopulmonary Autotransfusion System Sales in Value by Country (2018-2023)
8.2 Latin America Cardiopulmonary Autotransfusion System Forecasted Market Size by Country
8.2.1 Latin America Cardiopulmonary Autotransfusion System Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cardiopulmonary Autotransfusion System Sales in Value by Country (2024-2029)
9 Middle East and Africa Cardiopulmonary Autotransfusion System by Country
9.1 Middle East and Africa Cardiopulmonary Autotransfusion System Historic Market Size by Country
9.1.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cardiopulmonary Autotransfusion System Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cardiopulmonary Autotransfusion System Forecasted Market Size by Country
9.2.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Haemonetics
10.1.1 Haemonetics Company Information
10.1.2 Haemonetics Introduction and Business Overview
10.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Haemonetics Cardiopulmonary Autotransfusion System Products Offered
10.1.5 Haemonetics Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Cardiopulmonary Autotransfusion System Products Offered
10.2.5 Medtronic Recent Development
10.3 LivaNova
10.3.1 LivaNova Company Information
10.3.2 LivaNova Introduction and Business Overview
10.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2018-2023)
10.3.4 LivaNova Cardiopulmonary Autotransfusion System Products Offered
10.3.5 LivaNova Recent Development
10.4 Fresenius Kabi
10.4.1 Fresenius Kabi Company Information
10.4.2 Fresenius Kabi Introduction and Business Overview
10.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Products Offered
10.4.5 Fresenius Kabi Recent Development
10.5 Terumo
10.5.1 Terumo Company Information
10.5.2 Terumo Introduction and Business Overview
10.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Terumo Cardiopulmonary Autotransfusion System Products Offered
10.5.5 Terumo Recent Development
10.6 Wandong Health Sources
10.6.1 Wandong Health Sources Company Information
10.6.2 Wandong Health Sources Introduction and Business Overview
10.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Products Offered
10.6.5 Wandong Health Sources Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cardiopulmonary Autotransfusion System Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cardiopulmonary Autotransfusion System Industrial Chain Analysis
11.4 Cardiopulmonary Autotransfusion System Market Dynamics
11.4.1 Cardiopulmonary Autotransfusion System Industry Trends
11.4.2 Cardiopulmonary Autotransfusion System Market Drivers
11.4.3 Cardiopulmonary Autotransfusion System Market Challenges
11.4.4 Cardiopulmonary Autotransfusion System Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cardiopulmonary Autotransfusion System Distributors
12.3 Cardiopulmonary Autotransfusion System Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
